Kagan A - Search Results

1

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

Kagan A, Sheikh-Hamad D. Kagan A, et al. Clin Cardiol. 2010 Feb;33(2):62-6. doi: 10.1002/clc.20687. Clin Cardiol. 2010. PMID: 20186983 Free PMC article. Review.

2

Nephrogenic calcific arteriopathy.

Olivero JJ, Olivero JJ, Nguyen P, Kagan A. Olivero JJ, et al. Among authors: kagan a. Methodist Debakey Cardiovasc J. 2011 Oct-Dec;7(4):33-6. doi: 10.14797/mdcj-7-4-33. Methodist Debakey Cardiovasc J. 2011. PMID: 22143475 Review.

3

The heart and diabetic nephropathy.

Olivero JJ Jr, Nguyen PT, Olivero JJ, Kagan A. Olivero JJ Jr, et al. Among authors: kagan a. Methodist Debakey Cardiovasc J. 2010 Apr-Jun;6(2):9-14. doi: 10.14797/mdcj-6-2-9. Methodist Debakey Cardiovasc J. 2010. PMID: 20661187 Review. No abstract available.

4

Acute kidney injury after cardiovascular surgery: an overview.

Olivero JJ, Olivero JJ, Nguyen PT, Kagan A. Olivero JJ, et al. Among authors: kagan a. Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):31-6. doi: 10.14797/mdcj-8-3-31. Methodist Debakey Cardiovasc J. 2012. PMID: 23227284 Free PMC article. Review.

5

Weight Gain After Simultaneous Kidney and Pancreas Transplantation.

Knight RJ, Islam AK, Pham C, Graviss EA, Nguyen DT, Moore LW, Kagan A, Sadhu AR, Podder H, Gaber AO. Knight RJ, et al. Among authors: kagan a. Transplantation. 2020 Mar;104(3):632-639. doi: 10.1097/TP.0000000000002862. Transplantation. 2020. PMID: 31335775

6

Belatacept during pregnancy in renal transplant recipients: Two case reports.

Combs J, Kagan A, Boelkins M, Coscia L, Moritz M, Hofmann RM. Combs J, et al. Among authors: kagan a. Am J Transplant. 2018 Aug;18(8):2079-2082. doi: 10.1111/ajt.14911. Epub 2018 Jun 3. Am J Transplant. 2018. PMID: 29719109

7

Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.

Chen C, Ochoa LN, Kagan A, Chai H, Liang Z, Lin PH, Yao Q. Chen C, et al. Among authors: kagan a. Atherosclerosis. 2012 May;222(1):74-83. doi: 10.1016/j.atherosclerosis.2012.02.010. Epub 2012 Feb 13. Atherosclerosis. 2012. PMID: 22424734 Free PMC article.

8

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.

Todd DJ, Kagan A, Chibnik LB, Kay J. Todd DJ, et al. Among authors: kagan a. Arthritis Rheum. 2007 Oct;56(10):3433-41. doi: 10.1002/art.22925. Arthritis Rheum. 2007. PMID: 17907148

9

Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.

Nazarian RM, Mandal RV, Kagan A, Kay J, Duncan LM. Nazarian RM, et al. Among authors: kagan a. J Am Acad Dermatol. 2011 Apr;64(4):741-7. doi: 10.1016/j.jaad.2010.05.034. J Am Acad Dermatol. 2011. PMID: 21414498

10

Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.

Abujudeh HH, Kaewlai R, Kagan A, Chibnik LB, Nazarian RM, High WA, Kay J. Abujudeh HH, et al. Among authors: kagan a. Radiology. 2009 Oct;253(1):81-9. doi: 10.1148/radiol.2531082160. Epub 2009 Aug 25. Radiology. 2009. PMID: 19709997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results